We are live on
!
Find out more
TC
Truvestments Capital Portfolio holdings
AUM
$554M
1-Year Est. Return
32.49%
This Fund
S&P 500
This Quarter
Est. Return
+7.39%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$9.15M
(-6%)
Cap. Flow
-$18.1M
Cap. Flow
% of AUM
-12.5%
Top 10 Holdings %
Top 10 Hldgs %
26.79%
Holding
704
New
1
Increased
73
Reduced
49
Closed
564
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$269K |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$197K |
| 3 |
Altria Group
MO
|
+$144K |
| 4 |
MPT
Medical Properties Trust
MPT
|
+$127K |
| 5 |
ExxonMobil
XOM
|
+$117K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$582K |
| 2 |
Marathon Petroleum
MPC
|
+$200K |
| 3 |
AerCap
AER
|
+$196K |
| 4 |
XPO
XPO
|
+$195K |
| 5 |
Campbell Soup
CPB
|
+$186K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.31% |
| 2 | Healthcare | 10.05% |
| 3 | Consumer Staples | 8.95% |
| 4 | Communication Services | 7.78% |
| 5 | Industrials | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kimberly-Clark
KMB
$36.4B
| $1.66M | 1.15% |
12,095
+669
| +6% | +$90.5K |
|
27
Walt Disney
DIS
$181B
| $1.53M | 1.06% |
10,556
+359
| +4% | +$50.1K |
|
28
Waste Management
WM
$90.8B
| $1.52M | 1.05% |
13,355
+224
| +2% | +$25.3K |
|
29
Duke Energy
DUK
$97.4B
| $1.52M | 1.05% |
16,627
-61
| -0.4% | -$5.59K |
|
30
PepsiCo
PEP
$190B
| $1.49M | 1.03% |
10,898
+522
| +5% | +$71K |
|
|
TRTN
31
DELISTED
Triton International Limited
TRTN
| $1.49M | 1.03% |
36,932
+1,340
| +4% | +$49.6K |
|
32
Southern Company
SO
$107B
| $1.48M | 1.03% |
23,265
-79
| -0.3% | -$4.9K |
|
33
Verizon
VZ
$195B
| $1.43M | 0.99% |
23,221
-1,138
| -5% | -$68.6K |
|
34
Enbridge
ENB
$112B
| $1.41M | 0.98% |
35,518
-1,391
| -4% | -$52K |
|
35
Corning
GLW
$143B
| $1.39M | 0.96% |
47,691
-2,338
| -5% | -$67.8K |
|
36
Dominion Energy
D
$59.3B
| $1.29M | 0.9% |
15,637
+923
| +6% | +$75.4K |
|
37
Cardinal Health
CAH
$55.4B
| $1.27M | 0.88% |
25,120
+1,070
| +4% | +$55.3K |
|
38
Pfizer
PFE
$152B
| $1.27M | 0.88% |
34,200
-860
| -2% | -$30.6K |
|
39
Western Digital
WDC
$150B
| $1.26M | 0.87% |
26,320
-1,423
| -5% | -$59.4K |
|
|
40
Altria Group
MO
$114B
| $1.25M | 0.86% |
24,951
+3,057
| +14% | +$144K |
|
41
Archer Daniels Midland
ADM
$36.8B
| $1.24M | 0.86% |
26,718
-771
| -3% | -$32.9K |
|
42
General Mills
GIS
$19.6B
| $1.21M | 0.84% |
22,520
-2,774
| -11% | -$146K |
|
43
Blackstone
BX
$109B
| $1.18M | 0.82% |
21,150
-2,000
| -9% | -$104K |
|
44
Invesco
IVZ
$14B
| $1.11M | 0.77% |
61,856
+2,218
| +4% | +$37.8K |
|
|
45
ExxonMobil
XOM
$632B
| $1.11M | 0.77% |
15,886
+1,691
| +12% | +$117K |
|
46
Abbott
ABT
$186B
| $1.09M | 0.76% |
12,585
+61
| +0.5% | +$5.11K |
|
47
IBM
IBM
$223B
| $1.08M | 0.75% |
8,469
+360
| +4% | +$46.8K |
|
48
Lockheed Martin
LMT
$135B
| $1.08M | 0.75% |
2,771
+50
| +2% | +$19.2K |
|
49
Berkshire Hathaway Class B
BRK.B
$1.12T
| $1.04M | 0.72% |
4,588
+380
| +9% | +$82.5K |
|
50
Prudential Financial
PRU
$41.9B
| $961K | 0.67% |
10,255
-1,195
| -10% | -$110K |
|
Similar funds
CA
SVCM
CAM
TC
BT
QL
IQI
TCM
Truvestments Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Truvestments Capital held 704 positions worth $144M, down 6% from $154M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Truvestments Capital withdrew a net $18.1M in Q4 2019, closing 564 positions and reducing 49 holdings. Its most notable exit was Celgene Corp, an estimated $582K position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Truvestments Capital opened a new position in Vanguard FTSE Developed Markets ETF worth $204K.
- Truvestments Capital's largest Q4 2019 buy was Vanguard FTSE Developed Markets ETF: 4,627 shares worth $204K.
- Truvestments Capital added most to Bristol-Myers Squibb in Q4 2019, an estimated $269K increase.
- Truvestments Capital's biggest Q4 2019 reduction was Apple, cutting an estimated $151K.
- Truvestments Capital fully exited Celgene Corp in Q4 2019, selling an estimated $582K.
- Truvestments Capital's ten largest holdings make up 27% of its $144M portfolio in Q4 2019.
- Truvestments Capital opened 1 new position and closed 564 in Q4 2019.
- Truvestments Capital's portfolio value fell 6% quarter-over-quarter to $144M.
Based on Truvestments Capital's 13F filing for Q4 2019, filed 29 Jan 2020.